- Home
- TCBS vs CRVO Comparison
TCBS vs CRVO Comparison
Compare TCBS & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCBS | CRVO |
|---|---|---|
| Founded | 1934 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.0M | 47.7M |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | TCBS | CRVO |
|---|---|---|
| Price | $16.65 | $4.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.50 |
| AVG Volume (30 Days) | 1.5K | ★ 104.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | N/A | ★ $9,737,974.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $24.13 | ★ N/A |
| Revenue Growth | N/A | ★ 36.29 |
| 52 Week Low | $15.01 | $3.58 |
| 52 Week High | $20.00 | $16.50 |
Technical Indicators
Market Signals| Indicator | TCBS | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 47.89 | 41.39 |
| Support Level | $15.69 | $3.58 |
| Resistance Level | $16.69 | $5.44 |
| Average True Range (ATR) | 0.23 | 0.52 |
| MACD | -0.03 | 0.10 |
| Stochastic Oscillator | 18.92 | 40.12 |
Price Performance
Historical ComparisonAbout TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.